Based on CIRCULAR LETTER NUMBER: HK.02.02/I/2845/2021 CONCERNING THE HIGHEST RATE LIMIT FOR RESERVE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR) examination, the following is the highest Tariff Limit for the latest RT-PCR examination: a. For RT-PCR examination in Java and Bali, Rp. 495.000,-b. For RT-PCR examination outside Java and Bali, Rp. 525.000,- Note: The highest tariff limit…
Author: peduliadmin
Recently, Yayasan Peduli Hati Bangsa was involved in a research study on self-testing for Hepatitis C.In line with WHO’s goal to eliminate Hepatitis C as a public health threat by 2030, Yayasan Peduli Hati Bangsa together with researchers around the world, conducted a study which was eventually released by WHO as a guide for this…
Date: Saturday, 17 Juli 2021Time: 10:00-12:00 WIB Below is the video recording of the webinar
Date: Saturday, 17 Juli 2021Time: 10:00-12:00 WIB In the midst of the COVID-19 pandemic, Hepatitis B and C prevention, care and treatment services must continue. The general public and key populations must continue to increase their knowledge and current information about Hepatitis B and C in Indonesia so that they can access related services earlier.…
11 June 2021By: Liz Highleyman On June 10, 2021, the US Food and Drug Administration (FDA) extended its approval for Epclusa (sofosbuvir/velpatasvir) and Mavyret (glecaprevir/pibrentasvir) for the treatment of hepatitis C in children 3 years of age and older. Both combinations are effective against all genotypes of hepatitis C virus (HCV).Hepatitis C is rare in…